Singapore markets closed

Vaxcyte, Inc. (PCVX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
63.71+3.16 (+5.22%)
At close: 04:00PM EDT
63.71 0.00 (0.00%)
After hours: 04:20PM EDT
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
332,341
332,341
169,451
78,411
73,564
Selling general and administrative
60,700
60,700
39,810
25,259
16,017
Total operating expenses
388,276
388,276
207,330
102,085
87,103
Operating income or loss
-388,276
-388,276
-207,330
-102,085
-87,103
Interest expense
0
0
2
7
7
Total other income/expenses net
-76,897
-76,897
-24,509
1,671
-2,351
Income before tax
-402,266
-402,266
-223,485
-100,077
-89,217
Income from continuing operations
-402,266
-402,266
-223,485
-100,077
-89,217
Net income
-402,266
-402,266
-223,485
-100,077
-89,217
Net income available to common shareholders
-402,266
-402,266
-223,485
-100,077
-89,217
Basic EPS
-4.73
-4.14
-3.44
-1.93
-3.02
Diluted EPS
-4.73
-4.14
-3.44
-1.93
-3.02
Basic average shares
64,457
97,158
64,878
51,922
29,546
Diluted average shares
64,457
97,158
64,878
51,922
29,546